Atlantic health news — P.E.I. Prescription Drugs funding just got a $32-million, three-year renewal from Ottawa and the province, extending a program that has already saved Islanders $13.8 million on their medications. If you fill a prescription on the Island, this is your money on the table.
By Maplestime News Desk | Charlottetown, P.E.I. | October 3, 2026
Sources: Health Canada, Government of P.E.I. | Last updated: October 3, 2026
Key Takeaways
- Ottawa and P.E.I. will invest more than $32 million over three years to extend P.E.I. Prescription Drugs coverage through the Improving Affordable Access to Prescription Drugs (IAAPD) program.
- The announcement was made October 2 at the UPEI Faculty of Medicine and Health Sciences Centre in Charlottetown.
- IAAPD launched in 2021 with $35 million in prior funding and had saved Islanders $13.8 million as of March 2025.
The announcement landed Friday morning at 10 a.m. Atlantic time, at the UPEI Faculty of Medicine and Health Sciences Centre in Charlottetown. Heath MacDonald, the federal Minister of Agriculture and Agri-Food, delivered the news on behalf of federal Health Minister Marjorie Michel, alongside P.E.I. Premier Rob Lantz and Health Minister Cory Deagle. The deal: Ottawa and the province intend to put more than $32 million over three years behind P.E.I. Prescription Drugs coverage through the IAAPD program.
P.E.I. Prescription Drugs: What The Money Does
The Improving Affordable Access to Prescription Drugs program launched in 2021 as a small-province experiment with a big question behind it: can a modest jurisdiction actually move the needle on drug costs? The answer, so far, is yes. P.E.I. previously received $35 million for the 2021-22 to 2025-26 period, which went toward expanding the public drug formulary and lowering out-of-pocket costs for Islanders. As of March 2025, the program had saved Islanders $13.8 million.
The renewal keeps those formulary improvements and the cost-of-living savings intact for another three years. For a province of roughly 180,000 people, $13.8 million in savings is not pocket change — it is the difference between filling a prescription and skipping it for a lot of households.
Related: Canada Grocery Prices 2026 — What Canadians Are Paying at the Checkout
What Ottawa Is Saying
Federal Health Minister Marjorie Michel framed the extension as a partnership win:
“We are working with PEI to make prescription drugs more affordable for Islanders. This renewed federal funding will help PEI maintain improvements to its public drug coverage and continue delivering savings for Islanders.”
The optics of the venue were deliberate: the UPEI Faculty of Medicine and Health Sciences Centre, tying the funding announcement to the province’s still-young medical school and the broader push to keep health talent on the Island. MacDonald making the announcement on Michel’s behalf is a reminder that this federal government is running its Atlantic health file through multiple ministers — watch the execution, not just the press release.
Why This Matters For Islanders
Drug coverage is one of those cost-of-living fights that rarely makes national headlines but dominates kitchen-table conversations. Prescription prices in Canada are high by international standards, and smaller provinces have the least leverage against them. The P.E.I. Prescription Drugs approach — expanding the public formulary and absorbing costs — has now survived two funding cycles with measurable savings to show for it. The $32 million extension is a bet that the model keeps working.
The real question is whether other provinces will follow the Island’s lead, or whether this stays a small-province success story while bigger provinces chase bigger, slower pharmacare dreams.
Maplestime will provide updates from P.E.I. prescription drug funding as announcements are made.
Have a tip about P.E.I. health care? Email [email protected]
Have a correction? Email [email protected]
Is $13.8 million in savings proof that small provinces can beat the big drug-price problem — or just a drop in the prescription-cost bucket? Tell us in the comments. And share this with every Canadian who has ever skipped a prescription because of the price.
Enjoying Maplestime? Support independent Canadian journalism — no paywall, no corporate owners.
